Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Interfering | 16 | 2024 | 851 | 1.920 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 310 | 0.840 |
Why?
|
| RNA Interference | 6 | 2024 | 590 | 0.830 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2018 | 87 | 0.570 |
Why?
|
| Huntingtin Protein | 4 | 2022 | 138 | 0.470 |
Why?
|
| Prodrugs | 1 | 2014 | 31 | 0.460 |
Why?
|
| Lipids | 3 | 2019 | 306 | 0.390 |
Why?
|
| Oligonucleotides | 4 | 2021 | 208 | 0.380 |
Why?
|
| Huntington Disease | 2 | 2022 | 146 | 0.350 |
Why?
|
| Central Nervous System | 2 | 2024 | 192 | 0.340 |
Why?
|
| Tissue Distribution | 4 | 2019 | 283 | 0.250 |
Why?
|
| HeLa Cells | 5 | 2019 | 526 | 0.250 |
Why?
|
| Animals | 15 | 2024 | 19652 | 0.240 |
Why?
|
| Dystrophin | 1 | 2023 | 35 | 0.220 |
Why?
|
| Acetylgalactosamine | 2 | 2024 | 10 | 0.210 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2023 | 42 | 0.210 |
Why?
|
| Cholesterol | 3 | 2019 | 255 | 0.210 |
Why?
|
| Mice | 12 | 2024 | 10273 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2018 | 2099 | 0.190 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 70 | 0.180 |
Why?
|
| Genetic Therapy | 3 | 2023 | 738 | 0.170 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2017 | 104 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 2 | 2017 | 73 | 0.170 |
Why?
|
| Liver | 5 | 2024 | 783 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 3195 | 0.150 |
Why?
|
| Aptamers, Nucleotide | 1 | 2018 | 18 | 0.150 |
Why?
|
| Gene Silencing | 4 | 2024 | 376 | 0.150 |
Why?
|
| Extracellular Vesicles | 1 | 2018 | 41 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 558 | 0.150 |
Why?
|
| RNA | 2 | 2023 | 403 | 0.140 |
Why?
|
| Genome, Human | 1 | 2018 | 218 | 0.130 |
Why?
|
| Guanabenz | 1 | 2015 | 3 | 0.130 |
Why?
|
| Exosomes | 1 | 2016 | 42 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1538 | 0.120 |
Why?
|
| Peptides | 1 | 2018 | 545 | 0.120 |
Why?
|
| Gene Editing | 1 | 2018 | 301 | 0.110 |
Why?
|
| Apolipoproteins E | 2 | 2024 | 99 | 0.110 |
Why?
|
| Humans | 12 | 2024 | 59517 | 0.100 |
Why?
|
| Kidney | 3 | 2019 | 393 | 0.100 |
Why?
|
| Genetic Vectors | 1 | 2018 | 816 | 0.100 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2019 | 250 | 0.100 |
Why?
|
| Argonaute Proteins | 1 | 2013 | 128 | 0.090 |
Why?
|
| Alleles | 2 | 2022 | 422 | 0.090 |
Why?
|
| Neurons | 1 | 2016 | 860 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2023 | 133 | 0.080 |
Why?
|
| Phosphorylcholine | 2 | 2019 | 41 | 0.070 |
Why?
|
| Hepatocytes | 2 | 2019 | 191 | 0.070 |
Why?
|
| Nucleosides | 1 | 2007 | 11 | 0.070 |
Why?
|
| Ionic Liquids | 1 | 2007 | 8 | 0.070 |
Why?
|
| Female | 4 | 2019 | 30916 | 0.060 |
Why?
|
| Antagomirs | 1 | 2024 | 5 | 0.060 |
Why?
|
| Amyloidogenic Proteins | 1 | 2024 | 11 | 0.060 |
Why?
|
| Mice, Inbred mdx | 1 | 2023 | 18 | 0.060 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 35 | 0.060 |
Why?
|
| Luciferases, Firefly | 2 | 2014 | 17 | 0.060 |
Why?
|
| Amyloid | 1 | 2024 | 63 | 0.050 |
Why?
|
| Exons | 1 | 2023 | 193 | 0.050 |
Why?
|
| Chemical Engineering | 1 | 2022 | 9 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 194 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2021 | 20 | 0.050 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2021 | 12 | 0.050 |
Why?
|
| RNAi Therapeutics | 1 | 2021 | 12 | 0.050 |
Why?
|
| Organophosphonates | 1 | 2021 | 21 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2021 | 79 | 0.050 |
Why?
|
| Sheep | 1 | 2021 | 168 | 0.050 |
Why?
|
| Fibrosis | 1 | 2021 | 151 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1469 | 0.040 |
Why?
|
| Mutation | 2 | 2019 | 2445 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 1223 | 0.040 |
Why?
|
| Triglycerides | 1 | 2021 | 241 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 417 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2019 | 33 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 46 | 0.040 |
Why?
|
| Carbocyanines | 1 | 2019 | 29 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2019 | 72 | 0.040 |
Why?
|
| Solid-Phase Synthesis Techniques | 1 | 2018 | 3 | 0.040 |
Why?
|
| Propylene Glycols | 1 | 2018 | 9 | 0.040 |
Why?
|
| Organophosphorus Compounds | 1 | 2018 | 32 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2024 | 619 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2018 | 104 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2018 | 160 | 0.040 |
Why?
|
| Peptide Nucleic Acids | 1 | 2017 | 17 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 31 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2019 | 193 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2017 | 182 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 195 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 90 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2018 | 575 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2018 | 492 | 0.030 |
Why?
|
| Brain | 1 | 2024 | 1488 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 58 | 0.030 |
Why?
|
| Photolysis | 1 | 2014 | 16 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 1104 | 0.030 |
Why?
|
| Polystyrenes | 1 | 2014 | 31 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 288 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 375 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2073 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 193 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 125 | 0.030 |
Why?
|
| Obesity | 1 | 2021 | 1186 | 0.030 |
Why?
|
| Male | 2 | 2024 | 27584 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 664 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 870 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 1311 | 0.020 |
Why?
|